fingolimod hydrochloride has been researched along with Anxiety in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blecharz-Klin, K; Mirowska-Guzel, D; Piechal, A; Pyrzanowska, J; Strosznajder, RP; Wencel, PL | 1 |
| Al-Habahbeh, S; Al-Shudifat, AE; Al-Smadi, A; Alqudah, A; Bjørk, MH; Ennab, W; Gammoh, OS; Weshah, F | 1 |
| Dang, PT; Hale, MW; Kocovski, P; Marinis, S; Orian, JM; Tabassum-Sheikh, N | 1 |
| Bhatnagar, S; Corbett, B; Luz, S; Moorthy, GS; Pearson-Leary, J; Sotuyo, N; Zuppa, AF | 1 |
| Arjmand, S; Asadi-Shekaari, M; Basiri, M; Dahmardeh, N; Kalantaripour, T; Shabani, M | 1 |
| Amodio, N; Citraro, R; Constanti, A; De Sarro, C; De Sarro, G; Gallo Cantafio, ME; Leo, A; Russo, E | 1 |
| Al-Hussain, F; Al-Salloum, N; Alazwary, N; Daif, A; Howaidi, S; Saeedi, J | 1 |
| Borgel, F; Bourdeix, I; Bungener, C; Chouette, I; Heinzlef, O; Meite, M; Moreau, T; Rerat, K; Suchet, L | 1 |
8 other study(ies) available for fingolimod hydrochloride and Anxiety
| Article | Year |
|---|---|
Fingolimod Modulates the Gene Expression of Proteins Engaged in Inflammation and Amyloid-Beta Metabolism and Improves Exploratory and Anxiety-Like Behavior in Obese Mice.
Topics: Amyloid Precursor Protein Secretases; Animals; Anxiety; Aspartic Acid Endopeptidases; bcl-2-Associated X Protein; Cytokines; Diabetes Mellitus, Type 2; Fingolimod Hydrochloride; Gene Expression; Inflammation; Mice; Mice, Obese; Obesity; Receptors, Lysosphingolipid; RNA, Messenger | 2023 |
The association between fingolimod and mental health outcomes in a cohort of Multiple Sclerosis patients with stress.
Topics: Anxiety; Fingolimod Hydrochloride; Humans; Multiple Sclerosis; Outcome Assessment, Health Care; Sleep Initiation and Maintenance Disorders | 2023 |
Immunomodulation Eliminates Inflammation in the Hippocampus in Experimental Autoimmune Encephalomyelitis, but Does Not Ameliorate Anxiety-Like Behavior.
Topics: Animals; Anxiety; Behavior, Animal; Disease Models, Animal; Down-Regulation; Encephalomyelitis, Autoimmune, Experimental; Female; Fingolimod Hydrochloride; Hippocampus; Immunomodulation; Inflammation; Mice; Mice, Inbred C57BL; Microglia; Signal Transduction; Sphingosine-1-Phosphate Receptors; Up-Regulation | 2021 |
FTY720 (Fingolimod), a modulator of sphingosine-1-phosphate receptors, increases baseline hypothalamic-pituitary adrenal axis activity and alters behaviors relevant to affect and anxiety.
Topics: Animals; Anxiety; Fingolimod Hydrochloride; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Rats; Sphingosine-1-Phosphate Receptors | 2021 |
Modulation of sphingosine-1-phosphate receptor ameliorates harmaline-induced essential tremor in rat.
Topics: Animals; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Essential Tremor; Fingolimod Hydrochloride; Gait Disorders, Neurologic; Harmaline; Immunosuppressive Agents; Male; Neuroprotective Agents; Rats; Rats, Wistar; Receptors, Lysosphingolipid | 2017 |
Fingolimod Exerts only Temporary Antiepileptogenic Effects but Longer-Lasting Positive Effects on Behavior in the WAG/Rij Rat Absence Epilepsy Model.
Topics: Animals; Anticonvulsants; Antidepressive Agents; Anxiety; Behavior, Animal; Brain; Depression; Disease Models, Animal; Electroencephalography; Epilepsy, Absence; Fingolimod Hydrochloride; Immunosuppressive Agents; Learning; Male; Memory; Rats, Transgenic; Rats, Wistar; Rotarod Performance Test; TOR Serine-Threonine Kinases | 2017 |
Depression, anxiety and stress severities in multiple sclerosis patients using injectable versus oral treatments.
Topics: Administration, Oral; Adult; Anxiety; Cross-Sectional Studies; Depression; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Injections; Interferon beta-1a; Interferon beta-1b; Male; Multiple Sclerosis, Relapsing-Remitting; Natalizumab | 2017 |
Anxiety and Coping Strategy Changes in Multiple Sclerosis Patients Initiating Fingolimod: The GRACE Prospective Study.
Topics: Adaptation, Psychological; Adult; Anxiety; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Prospective Studies | 2017 |